ad-214-02
Showing 1 - 1 of 1
Gastroesophageal Reflux Disease Trial in Seoul (AD-214-02, Rabeprazole)
Completed
- Gastroesophageal Reflux Disease
- AD-214-02
- Rabeprazole
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jul 20, 2021